Aslan Pharmaceuticals Ltd ADR
(ASLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,504 | N/A | 100,818 | 14,324 | 12,060 |
| Receivables | N/A | N/A | 529 | N/A | 13 |
| Other current assets | 1,425 | 0 | 397 | 1,178 | 342 |
| TOTAL | $101,928 | $N/A | $101,744 | $15,502 | $12,415 |
| Non-Current Assets | |||||
| PPE Net | 20 | N/A | 8 | 13 | 20 |
| Investments And Advances | 644 | 0 | 0 | 0 | 192 |
| Intangibles | 11 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,251 | 0 | 466 | 566 | 637 |
| TOTAL | $2,926 | $N/A | $475 | $579 | $849 |
| Total Assets | $104,854 | $N/A | $102,219 | $16,082 | $13,264 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 138 | N/A | N/A | 3,519 | N/A |
| Accounts payable and accrued liabilities | 5,795 | 0 | 5,394 | 6,600 | 4,976 |
| Other current liabilities | N/A | N/A | N/A | 267 | 918 |
| TOTAL | $6,141 | $N/A | $5,556 | $10,658 | $6,221 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,750 | N/A | 15,098 | 15,183 | 18,103 |
| Other Non-Current Liabilities | 63 | 269 | 393 | 770 | 761 |
| TOTAL | $30,813 | $N/A | $15,492 | $15,577 | $18,596 |
| Total Liabilities | $36,954 | $N/A | $21,047 | $26,234 | $24,817 |
| Shareholders' Equity | |||||
| Common Shares | 63,020 | N/A | 63,009 | 61,826 | 61,367 |
| Retained earnings | -216,428 | N/A | -202,403 | -195,683 | -189,752 |
| Other shareholders' equity | 8,165 | 0 | -128 | 122 | 337 |
| TOTAL | $67,900 | $N/A | $81,172 | $-10,152 | $-11,553 |
| Total Liabilities And Equity | $104,854 | $0 | $102,219 | $16,082 | $13,264 |